A European technology company identified an acquisition target in India's fast-growing enterprise software sector. The deal timeline was tight. The seller had a competing offer on the table. Every week of delay risked losing the transaction entirely – a textbook lost-opportunity scenario in a high-growth market where timing determines whether a deal closes or collapses.
This case study describes how Ferraz & Whitmore structured an M&A transaction in India for a European acquirer, navigating competition clearance, foreign investment rules, and closing conditions under Indian corporate and commercial legislation. The engagement covered due diligence, share purchase agreement drafting, regulatory filings with multiple authorities, and post-signing milestone management. The matter was resolved within a defined regulatory window, preserving the client's first-mover position in the target market.
This account covers the client profile, the legal strategy adopted, key milestones, the complications encountered, and three transferable lessons applicable to comparable cross-border acquisitions in India.
Client profile and the challenge
The client was a mid-sized European technology group with no prior operational presence in India. The acquisition target was a privately held Indian company with a significant customer base across financial services and logistics sectors.
The challenge had three distinct layers. First, the transaction required compliance with India's foreign direct investment rules, which impose sector-specific conditions on inbound investment. Second, the combined turnover of the parties triggered mandatory pre-merger notification under Indian competition legislation – meaning the deal could not close until clearance was obtained from the Competition Commission of India (CCI). Third, the target's capital structure included foreign shareholding, which required prior approval from the Reserve Bank of India (RBI) under exchange control rules before the share transfer could be completed.
The client had initially underestimated the regulatory sequencing. Their internal timeline assumed a standard 60-day close. Our first task was to reset expectations and map the actual regulatory calendar before negotiations on price and structure were finalised.
For clients considering comparable transactions, our dedicated page on M&A advisory in India sets out the full range of regulatory conditions applicable to inbound acquisitions.
Legal strategy and key milestones
The core strategic choice was to sequence regulatory approvals in parallel rather than serially. Many acquirers file with the CCI only after signing. In this matter, we initiated the pre-filing process during final SPA negotiations. This required drafting a sufficiently complete description of the transaction for the CCI submission while the share purchase agreement (SPA) was still being negotiated.
The SPA itself was structured to reflect the multi-authority closing regime. Closing conditions included CCI clearance, RBI approval for the share transfer, and confirmation from the Securities and Exchange Board of India (SEBI) that no open offer obligation was triggered. Representations and warranties were calibrated to Indian corporate legislation, including compliance with the Companies Act 2013, which governs filings, directorial obligations, and shareholder rights at the target entity level.
Due diligence was conducted in parallel across four workstreams: corporate records and statutory registers, financial and tax compliance, employment and IP ownership, and pending litigation. The National Company Law Tribunal (NCLT) register was reviewed for any pending insolvency or restructuring proceedings against the target. No such proceedings existed, but the review identified a legacy dispute that required a specific indemnity provision in the SPA.
Key milestones unfolded as follows. Signing occurred at week four. The CCI filing was submitted at week five. RBI approval was applied for at week six. CCI clearance arrived at week eleven – within the standard review period under Indian competition rules. RBI confirmation followed at week thirteen. The transaction closed at week fifteen.
Complications encountered and how they were addressed
Three complications arose during the process. Each was foreseeable in principle but required active management to prevent delay.
First, the CCI filing required detailed market share data for the enterprise software segment. The parties disagreed on how to define the relevant market. A broader market definition reduced combined share and simplified the filing. A narrower definition was more accurate but risked a Phase II review. After analysis of the target's actual competitive position, the team recommended a market definition that was both defensible and consistent with CCI precedent in adjacent software sectors. The filing proceeded on that basis and was cleared without a Phase II referral.
Second, the due diligence process revealed that one tranche of the target's existing foreign shareholding had not been reported to the RBI within the statutory timeframe at the time of the original investment. This created a potential compliance gap under exchange control legislation. The team worked with Indian counsel to quantify the exposure and file a compounding application with the RBI. The compounding was completed before closing, eliminating the risk of the breach affecting the share transfer approval.
Third, the SPA's dispute resolution clause required attention. The client's standard template called for ICC arbitration seated in London. Indian corporate legislation and exchange control rules do not prohibit foreign-seated arbitration for share purchase disputes between a foreign acquirer and Indian shareholders. However, enforcement of an award against assets located in India involves additional steps under India's Arbitration and Conciliation Act. The clause was ultimately drafted to designate Singapore as the seat, reflecting a jurisdiction whose awards benefit from a well-established recognition pathway in Indian courts and whose procedural rules are familiar to both parties.
For context on how comparable regulatory conditions affect M&A structures across high-growth markets, the firm's case study on a M&A transaction in the UAE illustrates parallel dynamics in a Gulf jurisdiction.
To discuss how these regulatory considerations apply to your acquisition target in India, contact us at info@ferrazwhitmore.com.
Transferable lessons for cross-border acquisitions in India
Lesson one: map the regulatory sequence before fixing the timeline. In India, M&A transactions frequently involve multiple concurrent approval processes – CCI, RBI, and potentially SEBI – each with its own procedural calendar. An acquirer that fixes a closing date without accounting for this sequence will either miss the date or face pressure to close before all conditions are satisfied. The realistic base case for a transaction requiring CCI and RBI approval is fourteen to eighteen weeks from signing. Any shorter timeline should be treated as optimistic unless the transaction structure genuinely avoids one of the two regulatory triggers.
Lesson two: treat due diligence as a risk-pricing tool, not a compliance formality. The legacy RBI reporting gap discovered during this transaction could have become a material closing obstacle. Because it was identified early, it was resolved through compounding before closing. Acquirers who compress due diligence – often in competitive processes – carry that risk into the closing meeting. Indian corporate and exchange control legislation generates technical compliance gaps that are rarely disclosed voluntarily by sellers. A structured due diligence process under Indian corporate legislation, covering statutory registers, board resolutions, and prior foreign investment filings, is the primary mechanism for identifying these exposures before they affect price or timeline.
Lesson three: draft the SPA closing conditions to mirror the actual regulatory map. Closing conditions in an India M&A SPA must be specific to the approvals required for that transaction. Generic conditions – "all necessary regulatory approvals obtained" – create ambiguity at the closing meeting. The conditions in this transaction named each authority and specified the form of confirmation required. This precision eliminated disputes about whether a particular approval had been satisfied and gave both parties a shared, objective standard for closing readiness. The same discipline applies to the dispute resolution clause: the choice of arbitral seat has concrete enforcement consequences in India. Additionally. Those consequences should be assessed before the SPA is signed, not after a dispute arises.
Engaging a lawyer in India with cross-border M&A experience. or a law firm with India-specific advisory capacity. is particularly important in transactions that combine foreign investment rules. Competition notification. Additionally, complex SPA negotiation under time pressure.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients on M&A transactions and corporate matters across 46 jurisdictions. Our Asia-Pacific practice supports acquirers entering the Indian market through structured due diligence, regulatory filing management, and SPA negotiation aligned with local corporate legislation and exchange control rules. As a law firm with India cross-border advisory experience, we work with international investors and in-house legal teams who need results-oriented counsel across civil law and common law systems. Our attorneys have advised on inbound acquisition matters involving competition clearance, RBI approval processes, and NCLT compliance reviews. The firm's Lisbon base provides direct access to EU regulatory frameworks, while our common law expertise supports arbitration strategy and enforcement planning in English-speaking jurisdictions. To discuss your M&A transaction in India, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.